CC Pharma Agreement Bolsters Tilray’s UK Growth, Strengthening Distribution to Pharmacy and Hospital ChannelsNEW YORK and LONDON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Tilray Pharma the pharmaceutical division of Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), today announced that its European pharmaceutical distribution business, CC Pharma, has entered into a strategic agreement with Smartway Pharmaceuticals, a leading UK-based pharmaceutical distribution partner, to expand the availability of pharmaceutical pr ...

Tilray Brands (NASDAQ: TLRY) has been an atrocious investment to hold on to for some time. Over the past five years, shares of the cannabis and alcohol company have crashed a mammoth 98% in value. It has widely underperformed the S&P 500 (it's up 78% over that stretch). The problem with Tilray's stock is that there isn't really much reason to be excited about its future. It may talk about opportunities in international cannabis markets, but the main reason to invest in the Canadian-based company has been t ...

Core Insights - The meme stock phenomenon began in 2021 with GameStop, driven by retail traders on Reddit's WallStreetBets forum, leading to significant price surges due to short squeezes [1] - Investments in meme stocks from 2016 or at their IPOs have resulted in varied outcomes, with some stocks yielding massive gains while others have led to substantial losses [2] Investment Performance - A $1,000 investment in various meme stocks a decade ago would yield different values today, highlighting the volatility and potential of these stocks [3] - Notable performance includes: - GameStop (GME): $3,532 (+253%) - AMC Entertainment Holdings (AMC): $11 (-98.9%) - Palantir Technologies (PLTR): $14,659 (+1,366%) - Carvana (CVNA): $29,712 (+2,871%) - Roku (ROKU): $6,033 (+503%) [4] Market Trends - Meme stocks continue to emerge, indicating a persistent trend driven by social media sentiment rather than traditional business fundamentals [5]

Industry Overview - The cannabis industry is undergoing significant changes with new laws and regulations that support its development [1][2] - Investors are focusing on companies that demonstrate strong performance or are working towards substantial goals, which can lead to profitability [1] Investment Opportunities - In 2026, there is anticipation for a new marijuana stock run, with potential breakout opportunities for various cannabis stocks [2][3] - It is crucial for investors to prepare for the volatility inherent in the cannabis sector [2] Key Companies to Watch - **Tilray Brands, Inc.**: Engages in the research, cultivation, processing, and distribution of medical cannabis products across multiple regions including Canada, the US, and Europe [4] - Recently appointed Romano Beverage to enhance distribution in Illinois, indicating a strategic move to accelerate growth [5][6] - **Cronos Group Inc.**: Focuses on the cultivation, production, distribution, and marketing of cannabis products internationally [8] - Launched its Lord Jones® premium cannabis brand in Israel, highlighting its strategy to penetrate key markets [9][10] - **SNDL Inc.**: Involved in the production and distribution of cannabis products for the adult-use market in Canada [10] - Announced a share repurchase program authorizing the repurchase of up to C$100 million of its outstanding common shares, indicating confidence in its stock value [12][13]

Core Insights - Breckenridge Distillery has appointed Romano Beverage to manage distribution in Illinois, aiming to enhance its market presence and growth in the state [1][2][3] Company Overview - Breckenridge Distillery, founded in 2008, is recognized as the "World's Highest Distillery" and is known for its award-winning blended bourbon whiskey [5] - The distillery has received numerous accolades, including being a 3x Icons of Whisky and 10x Best American Blended winner at the World Whiskies Awards, and recently, its Port Cask Finish was named World's Best Finished Bourbon in 2024 [6] Distribution Strategy - Romano Beverage will oversee the full spirits collection of Breckenridge Distillery in Illinois, including bourbon whiskey, rum, vodka, gin, and the newly launched Mountain Shot [2][4] - The partnership is expected to leverage Romano's local infrastructure and relationships to enhance logistics, salesforce coverage, and retail activation [4] Brand Commitment - Breckenridge Distillery is dedicated to providing premium craft spirits to retailers and on-premise accounts in Illinois, emphasizing its commitment to quality and customer service [4]

DENSBORN, Germany, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Tilray Pharma the pharmaceutical division of Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), today announced that CC Pharma, its European pharmaceutical distribution business, has been named a TOP 100 Innovator in Germany, one of the country’s most respected and independent recognitions for innovation among small and mid-sized enterprises. CC Pharma operates a nationwide pharmaceutical distribution network serving more than 13,000 pharmacies across Germany ...

Core Insights - CC Pharma has been recognized as a TOP 100 Innovator in Germany, highlighting its innovative strength and role as a trusted partner in the European pharmaceutical market [1][3][4] Company Overview - CC Pharma operates a nationwide pharmaceutical distribution network serving over 13,000 pharmacies in Germany, providing access to a wide range of prescription and over-the-counter medicines [2] - The company is also a key player in the distribution of medical cannabis in Germany, utilizing its established infrastructure and regulatory expertise to enhance patient access [2][4] Award Significance - The TOP 100 Innovator Award has been recognizing companies for over 25 years based on their innovative management, forward-looking strategies, and sustainable competitiveness [3] - This award serves as a trusted signal to various stakeholders, including customers, suppliers, and financial institutions, affirming the company's market position [3] Leadership Statements - Rajnish Ohri, President of International at Tilray Brands, emphasized that the recognition reflects CC Pharma's commitment to innovation and its role in the pharmaceutical ecosystem [4] - Mathias Bossen, Managing Director of CC Pharma, stated that the award validates the team's efforts in continuous improvement and positions the company as a reliable partner in the pharmaceutical value chain [4] Operational Excellence - CC Pharma's selection as a TOP 100 Innovator underscores its disciplined innovation strategy and commitment to operational excellence in a highly regulated market [4] - The award also highlights CC Pharma's attractiveness as an employer and its significant contribution to Germany's healthcare supply chain [4]

Core Viewpoint - Tilray Brands stock has experienced a significant decline, dropping over 68% from its peak in October, with a current price of $7.45, indicating a bearish trend but potential for a bullish reversal pattern to emerge [1] Group 1: Stock Performance - Tilray Brands stock price has fallen to its lowest level since December, with a notable drop from $15.75 in December to $7.45 currently [1] - The AdvisorShares Pure US Cannabis ETF has also seen a decline, falling from $7.25 in December to $4.10 [1] Group 2: Reasons for Decline - The stock's decline is attributed to the lack of progress in cannabis rescheduling, as Attorney General Pam Bondi has not taken steps to reschedule cannabis from Schedule 1 to Schedule 3, despite requests from former President Donald Trump [1] - The rescheduling process is expected to take months or years, and it is not anticipated to provide immediate benefits to companies like Tilray Brands, which face challenges in the banking sector [1] Group 3: Business Performance - Tilray Brands reported a 3% increase in revenue for the second quarter, totaling $217 million, but gross profit decreased from $61.2 million to $57.5 million [1] - Cannabis revenue remained stable at $65.7 million, while distribution revenue increased significantly from $67.6 million to $85.3 million, becoming the largest segment [1] - The beverage segment, however, saw a decline in revenue from $63 million to $50 million, and the wellness segment remained flat at $14.6 million [1] - The net loss improved slightly from $43.5 million to $41.8 million, with analysts projecting single-digit revenue growth moving forward [1] Group 4: Technical Analysis - The stock has moved below key technical levels, including the 78.6% Fibonacci Retracement level at $7.73 and the 50-day and 100-day Exponential Moving Averages [1] - Signs of a potential double-bottom pattern are emerging at $7, with a neckline at $15, suggesting a possible rebound in the coming weeks [1] - The next resistance level to monitor is the Major S&R Pivot Point at $12.5, with historical volatility indicating potential for a pullback following any rebound [1]

Core Insights - Tilray Brands, Inc. is preparing for a major sports event on February 8, 2026, by offering exclusive game day experiences at its craft beer tap rooms across the U.S. [1] - The company aims to enhance fan engagement through special promotions, food, and entertainment options during the game [1][15]. Tap Room Promotions - Montauk Brewing Company is offering $10 crowlers and a buy-two-get-one-free deal on 6-packs leading up to the game [3]. - Blue Point Brewing Co will host a promotion where guests can win a 75" smart TV and is offering catering packages that need to be ordered by February 6 [4]. - SweetWater Brewing Co in Atlanta is providing live music and exclusive draft beer specials, along with game-ready to-go deals for $20 [5]. - Terrapin Beer Co will have extended hours and half-priced pints, along with food offerings from a food truck [6]. - Breckenridge Brewing is offering various to-go specials, including wings and beer packages [7][14]. - Atwater Brewery has a Super 60 Deal for $60, which includes pizza, wings, and a growler or 12-pack [11]. - 10 Barrel Brewing is promoting a Touchdown Meal Deal for $50, along with bingo and raffles for in-house guests [12]. - Hop Valley Brewing is offering a Jumbo Pretzel Pack and other to-go specials for fans [13]. Company Overview - Tilray Brands, Inc. is a global lifestyle and consumer packaged goods company with operations in multiple regions, including North America and Europe [15]. - The company focuses on creating memorable experiences through its diverse portfolio of brands, which includes cannabis, beverages, and wellness products [15].

Industry Overview - The global cannabis market is rapidly evolving, with a projected 14% CAGR through 2031, rising from an estimated $45 billion in 2026 [1] - President Trump's decision to federally reschedule marijuana in the United States marks a significant regulatory shift [1] Company Analysis: Tilray Brands - Tilray is the top cannabis producer in Canada by revenue and the fourth-largest craft beer brewer in the United States [3] - The company has seen a 36% year-over-year increase in international cannabis revenues and a 51% sequential increase, marking one of its strongest international quarters [4] - Tilray's beverage expansion began with the acquisition of SweetWater in December 2020 and has scaled significantly through subsequent acquisitions [5] - The company ended the second quarter of fiscal 2026 with approximately $292 million in cash and marketable securities, reducing debt by roughly $4 million [6] - Tilray's financials highlight strength in the international cannabis business while capitalizing on beverage and wellness products [17] Company Analysis: Canopy Growth - Canopy Growth's second-quarter fiscal 2026 was among its strongest, driven by a disciplined focus on fundamentals and renewed momentum in the adult-use cannabis business [7] - The company reported over $21 million in annualized savings through its expense reduction initiative, surpassing its $20 million target ahead of schedule [10] - Canopy Growth ended the quarter with $298 million in cash and cash equivalents, exceeding debt balances by $70 million [11] - The company is committed to the European market and has improved supply chain execution [9] Financial Performance - Over the past six months, Tilray Brands shares have climbed 31.3%, while Canopy Growth shares are up 8.7% [14] - Tilray Brands trades at a forward, five-year Price/Sales (P/S) of 0.98X, below its median of 2.16X, while Canopy Growth trades at 1.93X, also at a discount to its median of 2.80X [15] Earnings Estimates - The Zacks Consensus Estimate for Tilray Brands' fiscal 2026 loss per share stands at 56 cents, compared to 10 cents in the year-ago quarter [12] - The Zacks Consensus Estimate for Canopy Growth's fiscal 2026 loss currently stands at 21 cents per share, reflecting a 92.9% improvement from the year-over-year figure [13]